257 related articles for article (PubMed ID: 27172087)
21. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation.
Ponticelli C
Nephrol Dial Transplant; 2014 Jun; 29(6):1134-40. PubMed ID: 24335382
[TBL] [Abstract][Full Text] [Related]
22. The impact of kidney donor profile index on delayed graft function and transplant outcomes: A single-center analysis.
Zens TJ; Danobeitia JS; Leverson G; Chlebeck PJ; Zitur LJ; Redfield RR; D'Alessandro AM; Odorico S; Kaufman DB; Fernandez LA
Clin Transplant; 2018 Mar; 32(3):e13190. PubMed ID: 29314286
[TBL] [Abstract][Full Text] [Related]
23. Prolonged Ischemic Time, Delayed Graft Function, and Graft and Patient Outcomes in Live Donor Kidney Transplant Recipients.
Krishnan AR; Wong G; Chapman JR; Coates PT; Russ GR; Pleass H; Russell C; He B; Lim WH
Am J Transplant; 2016 Sep; 16(9):2714-23. PubMed ID: 27037866
[TBL] [Abstract][Full Text] [Related]
24. The risk of graft loss 5 years after kidney transplantation is increased if cold ischemia time exceeds 14 hours.
Hansson J; Mjörnstedt L; Lindnér P
Clin Transplant; 2018 Sep; 32(9):e13377. PubMed ID: 30098052
[TBL] [Abstract][Full Text] [Related]
25. A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.
Kassimatis T; Qasem A; Douiri A; Ryan EG; Rebollo-Mesa I; Nichols LL; Greenlaw R; Olsburgh J; Smith RA; Sacks SH; Drage M
Trials; 2017 Jun; 18(1):255. PubMed ID: 28587616
[TBL] [Abstract][Full Text] [Related]
26. The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications.
Cardinal H; Dieudé M; Hébert MJ
J Am Soc Nephrol; 2017 Feb; 28(2):400-406. PubMed ID: 27798244
[TBL] [Abstract][Full Text] [Related]
27. Effect of an Early Switch to Belatacept Among Calcineurin Inhibitor-Intolerant Graft Recipients of Kidneys From Extended-Criteria Donors.
Le Meur Y; Aulagnon F; Bertrand D; Heng AE; Lavaud S; Caillard S; Longuet H; Sberro-Soussan R; Doucet L; Grall A; Legendre C
Am J Transplant; 2016 Jul; 16(7):2181-6. PubMed ID: 26718625
[TBL] [Abstract][Full Text] [Related]
28. Delayed graft function in kidney transplantation.
Bahl D; Haddad Z; Datoo A; Qazi YA
Curr Opin Organ Transplant; 2019 Feb; 24(1):82-86. PubMed ID: 30540574
[TBL] [Abstract][Full Text] [Related]
29. Urinary mitochondrial DNA associates with delayed graft function following renal transplantation.
Jansen MPB; Pulskens WPC; Uil M; Claessen N; Nieuwenhuizen G; Standaar D; Hau CM; Nieuwland R; Florquin S; Bemelman FJ; Leemans JC; Roelofs JJTH
Nephrol Dial Transplant; 2020 Aug; 35(8):1320-1327. PubMed ID: 30590723
[TBL] [Abstract][Full Text] [Related]
30. Targeted donor complement blockade after brain death prevents delayed graft function in a nonhuman primate model of kidney transplantation.
Danobeitia JS; Zens TJ; Chlebeck PJ; Zitur LJ; Reyes JA; Eerhart MJ; Coonen J; Capuano S; D'Alessandro AM; Torrealba JR; Burguete D; Brunner K; Van Amersfoort E; Ponstein Y; Van Kooten C; Jankowska-Gan E; Burlingham W; Sullivan J; Djamali A; Pozniak M; Yankol Y; Fernandez LA
Am J Transplant; 2020 Jun; 20(6):1513-1526. PubMed ID: 31922336
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies to LG3 are associated with poor long-term survival after liver retransplantation.
Xu Q; McAlister VC; House AA; Molinari M; Leckie S; Zeevi A
Clin Transplant; 2021 Jul; 35(7):e14318. PubMed ID: 33871888
[TBL] [Abstract][Full Text] [Related]
32. Transplantation of kidneys from DCD and DBD donors who died after ligature asphyxiation: The UK experience.
Trotter PB; Jochmans I; Hulme W; Robb M; Watson C; Neuberger J; Andrew Bradley J
Am J Transplant; 2018 Nov; 18(11):2739-2751. PubMed ID: 29947090
[TBL] [Abstract][Full Text] [Related]
33. Double Pretransplant Positivity for Autoantibodies to LG3 and Angiotensin II Type 1 Receptor Is Associated With Alloimmune Vascular Injury in Kidney Transplant Recipients.
Carroll R; Turgeon J; Deayton S; Emery T; Bilogrevic F; Jahan S; Rimbaud AK; Georges B; Tavares-Brum A; Hébert MJ; Cardinal H
Transplant Direct; 2023 Feb; 9(2):e1437. PubMed ID: 36743234
[TBL] [Abstract][Full Text] [Related]
34. A novel therapy to attenuate acute kidney injury and ischemic allograft damage after allogenic kidney transplantation in mice.
Gueler F; Shushakova N; Mengel M; Hueper K; Chen R; Liu X; Park JK; Haller H; Wensvoort G; Rong S
PLoS One; 2015; 10(1):e0115709. PubMed ID: 25617900
[TBL] [Abstract][Full Text] [Related]
35. Donor kidney injury molecule-1 promotes graft recovery by regulating systemic necroinflammation.
Lee JY; Ismail OZ; Zhang X; Haig A; Lian D; Gunaratnam L
Am J Transplant; 2018 Aug; 18(8):2021-2028. PubMed ID: 29603641
[TBL] [Abstract][Full Text] [Related]
36. Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation.
Morath C; Döhler B; Kälble F; Pego da Silva L; Echterdiek F; Schwenger V; Živčić-Ćosić S; Katalinić N; Kuypers D; Benöhr P; Haubitz M; Ziemann M; Nitschke M; Emmerich F; Pisarski P; Karakizlis H; Weimer R; Ruhenstroth A; Scherer S; Tran TH; Mehrabi A; Zeier M; Süsal C
Front Immunol; 2020; 11():1886. PubMed ID: 32983110
[TBL] [Abstract][Full Text] [Related]
37. Urinary IL-8 is a marker of early and long-term graft function after renal transplantation.
Kwiatkowska E; Domański L; Bober J; Safranow K; Szymańska-Pasternak J; Sulecka A; Pawlik A; Ciechanowski K; Kwiatkowski S
Ren Fail; 2017 Nov; 39(1):484-490. PubMed ID: 28494217
[TBL] [Abstract][Full Text] [Related]
38. Defective postreperfusion metabolic recovery directly associates with incident delayed graft function.
Wijermars LG; Schaapherder AF; de Vries DK; Verschuren L; Wüst RC; Kostidis S; Mayboroda OA; Prins F; Ringers J; Bierau J; Bakker JA; Kooistra T; Lindeman JH
Kidney Int; 2016 Jul; 90(1):181-91. PubMed ID: 27188504
[TBL] [Abstract][Full Text] [Related]
39. Influence of pretransplant midodrine use on outcomes after kidney transplantation.
Pottebaum AA; Hagopian JC; Brennan DC; Gharabagi A; Horwedel TA
Clin Transplant; 2018 Sep; 32(9):e13366. PubMed ID: 30076650
[TBL] [Abstract][Full Text] [Related]
40. Pretransplant Recipient Circulating CD4+CD127lo/- Tumor Necrosis Factor Receptor 2+ Regulatory T Cells: A Surrogate of Regulatory T Cell-Suppressive Function and Predictor of Delayed and Slow Graft Function After Kidney Transplantation.
Nguyen MT; Fryml E; Sahakian SK; Liu S; Cantarovich M; Lipman M; Tchervenkov JI; Paraskevas S
Transplantation; 2016 Feb; 100(2):314-24. PubMed ID: 26425877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
